🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.16
-0.43 (-1.82%)
At close: Nov 20, 2026, 4:00 PM EST
23.16
0.00 (0.00%)
After-hours: Nov 20, 2026, 7:30 PM EST

Rapport Therapeutics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Rapport Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $64.21. The average 1-year stock price forecast is 177.25% higher than the current stock price, while the lowest is $47 (+102.94%) and the highest is $89 (+284.28%).

Price Target: $64.21 (+177.25%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$47$64.21$63.5$89
Change+102.94%+177.25%+174.18%+284.28%

Analyst Ratings

The average analyst rating for Rapport Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy111212121515
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total121313131616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JonesTrading
JonesTrading
Buy
Reiterates
$82
BuyReiterates$82+254.06%Nov 12, 2026
UBS
UBS
Buy
Maintains
$71 → $64
BuyMaintains$71 → $64+176.34%Nov 5, 2026
Guggenheim
Guggenheim
Buy
Reiterates
$70 → $66
BuyReiterates$70 → $66+184.97%Nov 5, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$66 → $63
BuyReiterates$66 → $63+172.02%Nov 5, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$50 → $47
BuyReiterates$50 → $47+102.94%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
20.01M
Revenue Next Year
n/a
from 20.01M
Decreased by -100.00%
EPS This Year
-3.23
from -2.86
EPS Next Year
-4.03
from -3.23
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----20.01M
Operating Income
-5.85M-36.18M-83.06M-125.10M-179.87M
Net Income
-11.62M-34.79M-78.31M-111.48M-163.96M
EPS
----2.86-3.23
Free Cash Flow
----88.09M-116.04M
No. Analysts
----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High20.1M
Avg20.0M
Low20.0M

Revenue Growth

Revenue Growth20272028
High
-100.0%
Avg
-100.0%
Low
-100.0%

EPS Forecast

EPS202620272028
High-2.73
Avg-3.23
Low-3.41

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-